BLNAX | CRAZX | BLNAX / CRAZX | |
Total Expense Ratio | 1.13 | 0.81 | 140% |
Annual Report Gross Expense Ratio | 1.13 | 0.81 | 140% |
Fund Existence | 9 years | 13 years | - |
Gain YTD | 10.679 | 12.592 | 85% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 2000 | 125% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 436M | 2.51B | 17% |
Annual Yield % from dividends | 1.34 | 2.26 | 59% |
Returns for 1 year | -1.75 | 10.12 | -17% |
Returns for 3 years | 25.41 | 31.58 | 80% |
Returns for 5 years | 26.97 | 13.51 | 200% |
Returns for 10 years | N/A | 37.63 | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
PJP | 95.65 | 1.25 | +1.32% |
Invesco Pharmaceuticals ETF | |||
FXC | 70.03 | 0.04 | +0.06% |
Invesco CurrencyShares® Canadian Dollar | |||
KDRN | 23.27 | N/A | N/A |
Kingsbarn Tactical Bond ETF | |||
FWD | 103.51 | -0.12 | -0.12% |
AB Disruptors ETF | |||
NEWZ | 28.35 | -0.04 | -0.13% |
EA Series Trust StockSnips AI-Powered Sentiment US All Cap ETF |